HAE (STOCKS)
Haemonetics Corporation
$90.380000
-0.960000 (-1.05%)
Prev close: $91.340000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Christopher A. Simon
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $4,331.43M
- Employees
- 3,023
- P/E (TTM)
- 44.55
- P/B (TTM)
- 4.96
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
6
Buy
4
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q1)
|
$1.14 | $1.09 | +0.0524 | +4.82% |
|
Mar 2026 (Q4)
|
$1.29 | $1.28 | +0.0054 | +0.42% |
|
Dec 2025 (Q3)
|
$1.31 | $1.26 | +0.0473 | +3.75% |
|
Sep 2025 (Q2)
|
$1.27 | $1.12 | +0.1487 | +13.26% |
Financial Statements
| Revenues | $1.35B |
| Benefits Costs and Expenses | $1.22B |
| Cost Of Revenue | $553.87M |
| Costs And Expenses | $1.22B |
| Gross Profit | $798.15M |
| Operating Expenses | $637.83M |
| Selling, General, and Administrative Expenses | $450.64M |
| Depreciation and Amortization | $110.07M |
| Research and Development | $59.71M |
| Operating Income/Loss | $160.32M |
| Income/Loss From Continuing Operations After Tax | $96.29M |
| Income/Loss From Continuing Operations Before Tax | $130.44M |
| Income Tax Expense/Benefit | $34.15M |
| Income Tax Expense/Benefit, Deferred | -$22.50M |
| Net Income/Loss | $96.29M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $96.29M |
| Net Income/Loss Available To Common Stockholders, Basic | $96.29M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $2.09 |
| Diluted Earnings Per Share | $2.07 |
| Basic Average Shares | 139,425,000 |
| Diluted Average Shares | 140,041,000 |
| Assets | $2.37B |
| Current Assets | $810.83M |
| Inventory | $306.74M |
| Other Current Assets | $504.09M |
| Noncurrent Assets | $1.55B |
| Fixed Assets | $303.78M |
| Intangible Assets | $434.51M |
| Other Non-current Assets | $816.28M |
| Liabilities | $1.53B |
| Current Liabilities | $263.24M |
| Accounts Payable | $56.34M |
| Wages | $38.15M |
| Other Current Liabilities | $168.75M |
| Noncurrent Liabilities | $1.27B |
| Long-term Debt | $1.19B |
| Other Non-current Liabilities | $76.86M |
| Equity | $837.10M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $837.10M |
| Liabilities And Equity | $2.37B |
| Net Cash Flow From Operating Activities | $328.15M |
| Net Cash Flow From Operating Activities, Continuing | $328.15M |
| Net Cash Flow From Investing Activities | -$168.78M |
| Net Cash Flow From Investing Activities, Continuing | -$168.78M |
| Net Cash Flow From Financing Activities | -$227.55M |
| Net Cash Flow From Financing Activities, Continuing | -$227.55M |
| Exchange Gains/Losses | -$1.34M |
| Net Cash Flow | -$69.51M |
| Net Cash Flow, Continuing | -$68.18M |
| Comprehensive Income/Loss | $90.90M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $90.90M |
| Other Comprehensive Income/Loss | -$5.39M |